Characterization of pyruvate dehydrogenase subunit B and enolase as plasminogen-binding proteins in Mycoplasma

Cindy Thomas1, Enno Jacobs1, Roger Dumke1

  • 1Dresden University of Technology, Medical Faculty Carl Gustav Carus, Institute of Medical Microbiology and Hygiene, Fetscherstrasse 74, D-01307 Dresden, Germany.

Insights

Mycoplasma pneumoniae utilizes surface-associated pyruvate dehydrogenase subunit B (PDHB) to bind human plasminogen, a key interaction potentially contributing to respiratory tract infections. This binding is mediated by a specific 12-amino acid region on PDHB.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Pathogen-Host Interactions

Background:

  • Mycoplasma pneumoniae is an obligate pathogen causing respiratory infections.
  • Surface-located glycolytic enzymes facilitate pathogen-host interactions by binding extracellular matrix components.
  • Understanding these interactions is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the binding of M. pneumoniae glycolytic enzymes, enolase and pyruvate dehydrogenase subunit B (PDHB), to human plasminogen.
  • To determine the surface localization of these enzymes and characterize the specific binding site for plasminogen on PDHB.

Main Methods:

  • Recombinant protein expression and purification.
  • Enzyme-plasminogen binding assays using polyclonal antisera.
  • Cell fractionation, colony blotting, mild proteolysis, and immunofluorescence for surface localization.
  • Peptide mapping to identify the plasminogen-binding site on PDHB.

Main Results:

  • Both enolase and PDHB of M. pneumoniae bind human plasminogen in a concentration-dependent manner.
  • PDHB was confirmed to be surface-associated, while enolase's surface localization was not definitively shown.
  • A novel 12-amino acid region (FPAMFQIFTHAA) on PDHB was identified as the exclusive binding site for human plasminogen.

Conclusions:

  • Surface-associated PDHB and enolase from M. pneumoniae bind human plasminogen.
  • The identified 12-amino acid region on PDHB is critical for plasminogen binding.
  • These interactions may play a significant role in the pathogenesis of M. pneumoniae infections.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Bacterial Phylum Tenericutes01:24

Bacterial Phylum Tenericutes

The phylum Tenericutes, which includes the single class Mollicutes, comprises bacteria that lack cell walls. The term "Mollicutes" derives from the Latin word mollis, meaning "soft." These organisms are among the smallest known and are commonly referred to as mycoplasmas due to the prominence of the genus Mycoplasma, which includes well-known human pathogens. Despite their inability to stain gram-positively (a result of their lack of cell walls), mycoplasmas are phylogenetically related to the...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: